[1] Baráth K, Huber AM, Stämpfli P, Varga Z, Kollias S Neuroradiology of cholesteatomas AJNR Am J Neuroradiol 2011 32(2):221-9
[2] Migirov L, Tal S, Eyal A.
MRI,
not CT,
to rule out recurrent cholesteatoma and avoid unnecessary second-look mastoidectomy. Isr Med Assoc J 2009:11;144–46
[3] Benjamin Henninger, Christian Kremser Diffusion weighted imaging for the detection and evaluation of cholesteatoma 2017 May 28; 9(5): 217–222.
[4] Nasr Mohamed M.
Osman, Ahmed Abdel Rahman Moustafa Talaat Abdel Hakim Ali The accuracy and sensitivity of diffusion-weighted magnetic resonance imaging with Apparent Diffusion Coefficients in diagnosis of recurrent cholesteatoma 2017; 4: 27–39.
[5] K.M.
Schwartz, J.I.
Lane, B.D.
Bolster and B.A.
Neff American Journal of Neuroradiology March 2011, 32 (3) 430-436
[6] Som PM, Curtin HD Swartz JD Temporal bone inflammatory disease.
In: Som PM, Curtin HD eds. Head and Neck Imaging. 3rd ed. St.
Louis: Mosby; 1996:1391–424
[6] Lehmann P, Saliou G, Brochart C et al 3T MR imaging of postoperative recurrent middle ear cholesteatomas: value of periodically rotated overlapping parallel lines with enhanced reconstruction diffusion-weighted MR imaging.AJNR Am J Neuroradiol 2009:30;423–27
[7] Jindal M, Doshi J, Srivastav M, et al.
Diffusion-weighted magnetic resonance imaging in the management of cholesteatoma. Eur Arch Otorhinolaryngol 2010:267;181–85
[8] Schwartz KM, Lane JI, Neff BA, et al. Diffusion-weighted imaging for cholesteatoma evaluation. ENT J.2010;89:E14–19
[9] Ahmed FathyAbdel Ghany Diagnosis of recurrent cholesteatoma using diffusion weighted MRI June 2015,
Pages 391-395